[HTML][HTML] Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
PS Rawat, A Jaiswal, A Khurana, JS Bhatti… - Biomedicine & …, 2021 - Elsevier
Doxorubicin (Dox) is a secondary metabolite of the mutated strain of Streptomyces peucetius
var. Caesius and belongs to the anthracyclines family. The anti-cancer activity of Dox is …
var. Caesius and belongs to the anthracyclines family. The anti-cancer activity of Dox is …
Molecular mechanism of doxorubicin-induced cardiomyopathy–An update
Doxorubicin is utilized for anti-neoplastic treatment for several decades. The utility of this
drug is limited due to its side effects. Generally, doxorubicin toxicity is originated from the …
drug is limited due to its side effects. Generally, doxorubicin toxicity is originated from the …
Doxorubicin-induced cardiotoxicity: an overview on pre-clinical therapeutic approaches
Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (eg,
ovary, breast, and gastrointestinal cancers). This anti-cancer drug has various side effects …
ovary, breast, and gastrointestinal cancers). This anti-cancer drug has various side effects …
[HTML][HTML] Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies
Y Octavia, CG Tocchetti, KL Gabrielson… - Journal of molecular and …, 2012 - Elsevier
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of
cardiotoxicity. It has been calculated that approximately 10% of patients treated with …
cardiotoxicity. It has been calculated that approximately 10% of patients treated with …
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
J Halkein, SP Tabruyn, M Ricke-Hoch… - The Journal of …, 2013 - Am Soc Clin Investig
Peripartum cardiomyopathy (PPCM) is a life-threatening pregnancy-associated
cardiomyopathy in previously healthy women. Although PPCM is driven in part by the 16 …
cardiomyopathy in previously healthy women. Although PPCM is driven in part by the 16 …
The role of biomarkers in cardio-oncology
K Ananthan, AR Lyon - Journal of cardiovascular translational research, 2020 - Springer
In the field of cardio-oncology, it is well recognised that despite the benefits of chemotherapy
in treating and possibly curing cancer, it can cause catastrophic damage to bystander …
in treating and possibly curing cancer, it can cause catastrophic damage to bystander …
Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity
W Ma, S Wei, B Zhang, W Li - Frontiers in Cell and Developmental …, 2020 - frontiersin.org
Homeostatic regulation of cardiomyocytes plays a crucial role in maintaining the normal
physiological activity of cardiac tissue. Severe cardiotoxicity results in cardiac diseases …
physiological activity of cardiac tissue. Severe cardiotoxicity results in cardiac diseases …
Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance
HS Al-Malky, SE Al Harthi… - Journal of Oncology …, 2020 - journals.sagepub.com
Background Doxorubicin is one of the most commonly prescribed and time-tested anticancer
drugs. Although being considered as a first line drug in different types of cancers, the two …
drugs. Although being considered as a first line drug in different types of cancers, the two …
[HTML][HTML] New signal transduction paradigms in anthracycline-induced cardiotoxicity
Anthracyclines, such as doxorubicin, are the most potent and widely used chemotherapeutic
agents for the treatment of a variety of human cancers, including solid tumors and …
agents for the treatment of a variety of human cancers, including solid tumors and …
Cancer therapy–induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies
VS Hahn, DJ Lenihan, B Ky - Journal of the American Heart …, 2014 - Am Heart Assoc
The patient is a 63-year-old man with a history of wellcontrolled hypertension who is
diagnosed with diffuse large B-cell lymphoma and treated with a doxorubicincontaining …
diagnosed with diffuse large B-cell lymphoma and treated with a doxorubicincontaining …